RenovoRx RNXT
NASDAQ RNXT
$1.22 +0.04 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST

RenovoRx (RNXT) Gross Margin (2025 - 2026)

Updated

RenovoRx (RNXT) reported Gross Margin of 84.27% for Q2 2026, up 20.29 percentage points from 63.98% a year earlier but down 0.81 percentage points from the prior quarter.

Analysis

RenovoRx (RNXT) Gross Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, RenovoRx's Gross Margin came in at 84.41%; for FY2025, it came in at 70.88%, down 29.12 percentage points from FY2024.

  • By year, Gross Margin came in at 100.00% in FY2024.
  • Five-year quarterly Gross Margin spans a low of 52.28% in Q1 2025 and a high of 88.24% in Q4 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 85.08% (Q1 2026), 88.24% (Q4 2025) and 80.08% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 42.28%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 56.75%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 58.54%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 68.37%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 64.99%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 65.15%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 66.72%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 78.48%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 24.50%
10 RenovoRx 56.86 Mn 17.54 Mn 878,000.00 82.36%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 82.36%
Jun 30, 2026 84.27%
Mar 31, 2026 85.08%
Dec 31, 2025 88.24%
Sep 30, 2025 80.08%
Jun 30, 2025 63.98%
Mar 31, 2025 52.28%
API Access

RenovoRx Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=RNXT&period=max&api_key=YOUR_API_KEY